Sertraline and Phenytoin Drug Interaction in a Geriatric Patient

This report presents the case of a 78-year-old man residing in a nursing home who presented with a 2-month history of increasing lethargy and confusion. These symptoms coincided with the initiation of sertraline in the patient. Among other medications, he was also taking phenytoin. The medical team concluded that the cause of the patient’s lethargy and confusion was a drug interaction between sertraline and phenytoin. Phenytoin was held, while the sertraline was slowly tapered to discontinuation. The patient’s symptoms resolved soon thereafter. Future research is needed to better guide clinicians in appropriate selection, dosing, and monitoring of selective serotonin reuptake inhibitors with concomitant phenytoin use.

[1]  Edoardo Spina,et al.  Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. , 2008, Clinical therapeutics.

[2]  John R Horn,et al.  Proposal for a New Tool to Evaluate Drug Interaction Cases , 2007, The Annals of pharmacotherapy.

[3]  G. MacQueen,et al.  The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders. , 2006, CNS drug reviews.

[4]  E. Spina,et al.  Metabolic drug interactions with new psychotropic agents , 2003, Fundamental & clinical pharmacology.

[5]  F. Belpaire,et al.  Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update. , 2002, Current drug metabolism.

[6]  D. Greenblatt,et al.  Human cytochromes mediating sertraline biotransformation: seeking attribution. , 1999, Journal of clinical psychopharmacology.

[7]  S. Tolbert,et al.  Elevated serum phenytoin concentrations associated with coadministration of sertraline. , 1997, Journal of clinical psychopharmacology.

[8]  A. Richens Clinical Pharmacokinetics of Phenytoin , 1979, Clinical pharmacokinetics.

[9]  J. Markowitz,et al.  Clinical Pharmacokinetics of Sertraline , 2002, Clinical pharmacokinetics.

[10]  C. Hiemke,et al.  Pharmacokinetics of selective serotonin reuptake inhibitors. , 2000, Pharmacology & therapeutics.

[11]  D. Greenblatt,et al.  Inhibition of CYP2C9 by selective serotonin reuptake inhibitors in vitro: studies of phenytoin p-hydroxylation. , 1997, British journal of clinical pharmacology.

[12]  F J Durgin,et al.  Depression in the elderly. , 1978, Comprehensive therapy.